The variability in beta-cell function in placebo-treated subjects with type 2 diabetes: application of the weight-HbA1c-insulin-glucose (WHIG) model

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)
34 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)487-497
Number of pages11
JournalBritish Journal of Clinical Pharmacology
Volume83
Issue number3
DOIs
Publication statusPublished - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research programs

  • EMC OR-01

Cite this